Inhibition of in vitro hepatitis B virus replication by lentivirus-mediated short-hairpin RNA against HBx.
10.3350/kjhep.2009.15.1.15
- Author:
Jin Wook KIM
1
;
Sang Hyub LEE
;
Young Soo PARK
;
Sook Hyang JEONG
;
Nayoung KIM
;
Dong Ho LEE
Author Information
1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Seoul National University Bungdang Hospital, Seongnam, Korea. kimjw@snubh.org
- Publication Type:Original Article ; English Abstract
- Keywords:
Hepatitis B virus;
Lentivirus;
MicroRNAs;
RNA interference;
siRNA
- MeSH:
Cell Line, Tumor;
Genetic Vectors;
Hepatitis B virus/*genetics/growth & development/physiology;
Humans;
Lentivirus/*genetics;
*RNA Interference;
RNA, Viral/metabolism;
Trans-Activators/*antagonists & inhibitors/genetics/metabolism;
*Virus Replication
- From:The Korean Journal of Hepatology
2009;15(1):15-24
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUNDS/AIMS: Hepatitis B virus (HBV) replicates via RNA intermediates, which could serve as targets for RNA interference (RNAi). Vector-mediated short-hairpin RNA (shRNA) can induce sustained RNAi in comparison to small interfering RNA. Lentiviral vector is known to induce prolonged RNAi with high transduction efficiency. In this study, we sought to test the in vitro efficacy of shRNA delivered by a lentiviral vector in suppressing the replication of HBV. METHODS: Two shRNA sequences against the hepatitis B viral protein HBx (sh1580 and sh1685) were cloned downstream of the U6 promoter in an HIV-based plasmid to generate third-generation lentiviral vectors. HepAD38 cells were transduced with anti-HBx lentiviral vectors, and HBV replication was induced for 5 days. HBV DNA was isolated and quantified using real-time PCR. RESULTS: Lentiviral vectors encoding the shRNA against HBV transduced HepAD38 cells with high efficacy. The total intracellular HBV DNA content was significantly reduced by both sh1580 and sh1685 (2.9% and 12.0%, respectively; P<0.05). HBV covalently closed circular DNA (cccDNA) was also suppressed significantly (19.7% and 25.5%, respectively; P<0.05). CONCLUSIONS: Lentivirus-mediated delivery of shRNA against HBx can effectively suppress the replication of HBV and reduce HBV cccDNA in cell culture systems.
